Skip to main
IDXG

Interpace Diagnostics (IDXG) Earnings Dates & Reports

Interpace Diagnostics (IDXG) Most Recent Earnings

Report Date
Period EndingQ1 2021
Est. EPS-$1.01
Actual EPS-$1.02
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Interpace Diagnostics (IDXG) Earnings per Share (EPS) History

Signup for full access
Browse free

Interpace Diagnostics (IDXG) Latest Earnings

The value each IDXG share was expected to gain vs. the value each share gained.

Interpace Diagnostics (IDXG) reported its most recent earnings on for Q1 2021, posting earnings per share (EPS) of -$1.02. This exceeded analysts' expectations of -$1.01 by 0.99%, marking a Miss.

For comparison, Interpace Diagnostics reported EPS of -$2.31 in the same quarter last year.

The company is expected to announce its next earnings report on , with analysts projecting an EPS of $0.

Interpace Diagnostics (IDXG) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q3 2021
-$0.84
Q2 2021
-$0.83
Q1 2021
-$1.01-$1.02+0.99%
Q4 2020
-$2.01
Q3 2020
-$1.20-$1.53+27.50%
View all

Interpace Diagnostics (IDXG) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Interpace Diagnostics’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange

Interpace Diagnostics (IDXG) Earnings FAQs

Interpace Diagnostics (IDXG) last reported earnings on May 11, 2021 for Q1 2021, posting an EPS of -$1.02, which Miss the estimate of -$1.01 by 0.99%.

For Q1 2021, Interpace Diagnostics (IDXG) reported an EPS of -$1.02, missing analysts' estimate of -$1.01 by 0.99%.

For Q1 2021, Interpace Diagnostics (IDXG) Miss expectations with an actual EPS of -$1.02 vs. an estimated EPS of -$1.01.

Following the last earnings report on May 11, 2021, Interpace Diagnostics (IDXG)'s stock price moved — from — to —.

The next Interpace Diagnostics (IDXG) earnings call is scheduled for Nov. 10, 2021, where executives will discuss financial results and outlook.

Interpace Diagnostics (IDXG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.